UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature structural & molecular biology, ISSN 1545-9993, 10/2010, Volume 17, Issue 10, pp. 1247 - 1254
Biochemistry & Molecular Biology | Biophysics | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Recombination, Genetic - physiology | DNA, Neoplasm - metabolism | Humans | Neoplasm Proteins - physiology | DNA Repair - physiology | Molecular Sequence Data | Structure-Activity Relationship | DNA Breaks, Double-Stranded | BRCA2 Protein - physiology | Breast Neoplasms - metabolism | Base Sequence | Tumor Suppressor Proteins - chemistry | Tumor Suppressor Proteins - genetics | Female | Protein Interaction Domains and Motifs | Nuclear Proteins - genetics | Nucleic Acid Conformation | Fanconi Anemia Complementation Group N Protein | Peptide Fragments - metabolism | Neoplasm Proteins - chemistry | Nuclear Proteins - chemistry | Poly(ADP-ribose) Polymerase Inhibitors | Protein Interaction Mapping | Tumor Suppressor Proteins - physiology | Peptide Fragments - chemistry | Apoptosis Regulatory Proteins | Models, Biological | Rad51 Recombinase - chemistry | Rad51 Recombinase - physiology | BRCA2 Protein - chemistry | Nuclear Proteins - physiology | Poly (ADP-Ribose) Polymerase-1 | Breast cancer | Genetic aspects | Research | BRCA mutations | Ovarian cancer | Proteins | Mutation | Molecular biology | Prostate cancer | Index Medicus | RAD51 | homologous recombination | BRCA2 | PALB2
Journal Article
Trends in biochemical sciences (Amsterdam. Regular ed.), ISSN 0968-0004, 06/2016, Volume 41, Issue 6, pp. 491 - 507
homology search | self-assembly | total internal reflection fluorescence (TIRF) | single molecule imaging | RAD51 | recombination | Förster resonance energy transfer (FRET) | Recombination | Self-assembly | Homology search | Single molecule imaging | Total internal reflection fluorescence (TIRF) | DNA, Bacterial - metabolism | Humans | Homologous Recombination | DNA, Bacterial - chemistry | DNA, Single-Stranded - genetics | Escherichia coli - metabolism | Rec A Recombinases - genetics | Rad51 Recombinase - metabolism | Rec A Recombinases - metabolism | Recombinational DNA Repair | Rad51 Recombinase - genetics | DNA, Single-Stranded - metabolism | Models, Molecular | Escherichia coli Proteins - metabolism | DNA, Single-Stranded - chemistry | Sequence Homology, Amino Acid | BRCA2 Protein - metabolism | DNA, Bacterial - genetics | Escherichia coli - genetics | Rad51 Recombinase - chemistry | Escherichia coli Proteins - genetics | Protein Binding | Rec A Recombinases - chemistry | BRCA2 Protein - chemistry | DNA Damage | Escherichia coli Proteins - chemistry | Gene Expression Regulation, Bacterial | BRCA2 Protein - genetics | Proteins | Online information services | Information services | Search and rescue operations | Internet/Web search services | Online services | Molecular biology | Chromosomes | Index Medicus | Single-molecule imaging | Förster Resonance Energy Transfer (FRET)
Journal Article
Biochemistry and cell biology, ISSN 0829-8211, 2016, Volume 94, Issue 5, pp. 407 - 418
Journal Article
Molecular cell, ISSN 1097-2765, 09/2017, Volume 67, Issue 5, pp. 867 - 881.e7
Journal Article
5.
Full Text
RI-1: A chemical inhibitor of RAD51 that disrupts Homologous recombination in human cells
Nucleic acids research, ISSN 0305-1048, 08/2012, Volume 40, Issue 15, pp. 7347 - 7357
Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Rad51 Recombinase - metabolism | Pyrroles - metabolism | Antibiotics, Antineoplastic - pharmacology | Enzyme Inhibitors - metabolism | Homologous Recombination - drug effects | Cross-Linking Reagents - pharmacology | Humans | Enzyme Inhibitors - pharmacology | Morpholines - pharmacology | Morpholines - metabolism | Rad51 Recombinase - antagonists & inhibitors | Morpholines - chemistry | Protein Subunits - metabolism | Mitomycin - pharmacology | Pyrroles - pharmacology | Enzyme Inhibitors - chemistry | Rad51 Recombinase - chemistry | Cell Line, Tumor | Pyrroles - chemistry | Cysteine - metabolism | DNA Damage | Index Medicus | Drugs | Rad51 protein | Cysteine | homologous recombination | Filaments | DNA damage | replication protein A | genomics | Tumor cell lines | Gene conversion | DNA repair | Monomers | Genome Integrity, Repair and
Journal Article
Oncogene, ISSN 0950-9232, 07/2013, Volume 32, Issue 30, pp. 3552 - 3558
RAD52 | RAD51 | BRCA1 | Synthetic lethality | BRCA2 | PALB2 | Biochemistry & Molecular Biology | Oncology | Genetics & Heredity | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Cell Survival - drug effects | DNA Repair - drug effects | Rad51 Recombinase - genetics | Humans | RNA, Small Interfering - pharmacology | Gene Silencing | Genes, Lethal - physiology | Cell Survival - genetics | DNA Repair - genetics | Rad52 DNA Repair and Recombination Protein - genetics | Rad52 DNA Repair and Recombination Protein - physiology | Gene Knockdown Techniques | Homologous Recombination - physiology | Genes, BRCA1 - physiology | Genes, BRCA2 - physiology | Genes, Lethal - genetics | Tumor Suppressor Proteins - genetics | Rad51 Recombinase - physiology | Cell Line, Tumor | Homologous Recombination - genetics | Gene Expression Regulation, Neoplastic - drug effects | Nuclear Proteins - genetics | Fanconi Anemia Complementation Group N Protein | Physiological aspects | Research | Genetic recombination | BRCA mutations | Rad51 proteins | Epigenetics | Genetic engineering | Gene therapy | Cancer therapies | Index Medicus | synthetic lethality
Journal Article
Cell reports (Cambridge), ISSN 2211-1247, 10/2017, Volume 21, Issue 2, pp. 333 - 340
replication | RAD51 | recombination | Fanconi anemia | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Rad51 Recombinase - metabolism | Xenopus | Animals | Rad51 Recombinase - genetics | Adenosine Triphosphate - metabolism | Humans | Protein Binding | DNA Replication | Fanconi Anemia - genetics | Mutation | Protein Stability | MRE11 Homologue Protein - metabolism | Index Medicus
Journal Article
Molecular cell, 09/2017, Volume 67, Issue 5, p. 867
Genomic Instability | Xenopus Proteins - genetics | Humans | Male | DNA-Binding Proteins - metabolism | MRE11 Homologue Protein | Time Factors | Endodeoxyribonucleases - metabolism | DNA - biosynthesis | Female | Xenopus laevis - genetics | Exodeoxyribonucleases - genetics | Binding Sites | DNA Helicases - genetics | Rad51 Recombinase - metabolism | Rad51 Recombinase - genetics | DNA Replication | Saccharomyces cerevisiae Proteins - genetics | DNA-Binding Proteins - genetics | DNA - genetics | DNA Helicases - metabolism | Endodeoxyribonucleases - genetics | Animals | BRCA2 Protein - metabolism | Replication Origin | Xenopus laevis - metabolism | Exodeoxyribonucleases - metabolism | Saccharomyces cerevisiae Proteins - metabolism | Protein Binding | Xenopus Proteins - metabolism | Mutation | DNA Polymerase III - metabolism | BRCA2 Protein - genetics | DNA Polymerase I - metabolism
Journal Article
EMBO molecular medicine, ISSN 1757-4676, 03/2013, Volume 5, Issue 3, pp. 353 - 365
small molecule | cancer | CML | RAD51 | inhibitor | Inhibitor | Small molecule | Cancer | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Homologous Recombination - drug effects | Apoptosis - drug effects | Neoplastic Stem Cells - drug effects | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Proteasome Inhibitors - metabolism | RNA Interference | Time Factors | Neoplastic Stem Cells - pathology | Binding Sites | Rad51 Recombinase - metabolism | Tetrahydroisoquinolines - pharmacology | Pyrimidines - pharmacology | Piperazines - pharmacology | Drug Resistance, Neoplasm - genetics | Fusion Proteins, bcr-abl - antagonists & inhibitors | Rad51 Recombinase - chemistry | Cell Line, Tumor | Mice, Inbred NOD | Mice | Molecular Docking Simulation | Protein Processing, Post-Translational | Mutation | Proteasome Endopeptidase Complex - metabolism | Protein-Tyrosine Kinases - antagonists & inhibitors | Protein Multimerization | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Rad51 Recombinase - antagonists & inhibitors | Antineoplastic Agents - metabolism | Dose-Response Relationship, Drug | Indoles - metabolism | Protein-Tyrosine Kinases - genetics | Transfection | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Female | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Benzamides - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Proteasome Inhibitors - pharmacology | Rad51 Recombinase - genetics | Mice, SCID | Imatinib Mesylate | Fusion Proteins, bcr-abl - genetics | Animals | Tumor Burden - drug effects | Tetrahydroisoquinolines - metabolism | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Antimitotic agents | Care and treatment | Invisibility | Nuclear radiation | Proteolysis | Analysis | Drug resistance | Antineoplastic agents | Cell proliferation | BCR protein | Leukemia | DNA damage | Homologous recombination | Recombinase | Kinases | Cancer therapies | Experiments | Rad51 protein | Ionizing radiation | Granulocytes | Cell cycle | Bone marrow | Deoxyribonucleic acid--DNA | CD34 antigen | Medical research | Imatinib | Cell survival | Breast cancer | Chronic myeloid leukemia | Progenitor cells | Survival analysis | Stem cells | Apoptosis | Index Medicus
Journal Article
International journal of cancer, ISSN 0020-7136, 10/2017, Volume 141, Issue 7, pp. 1286 - 1294
“BRCAness,” chemotherapy | radiotherapy | RAD51 | prognosis | Life Sciences & Biomedicine | Oncology | Science & Technology | Neoplasms - metabolism | Rad51 Recombinase - metabolism | Cell Proliferation - genetics | Rad51 Recombinase - genetics | Recombinational DNA Repair - genetics | Humans | Radiation Tolerance - genetics | Male | DNA Repair - genetics | DNA, Neoplasm - drug effects | Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use | Neoplasms - drug therapy | Polymorphism, Genetic | Drug Resistance, Neoplasm - genetics | Neoplasms - genetics | Biomarkers, Tumor - metabolism | Genes, BRCA2 | Female | Neoplasms - radiotherapy | Biomarkers, Tumor - genetics | Genes, BRCA1 | DNA, Neoplasm - radiation effects | Precision Medicine | Medical research | Chemotherapy | DNA | Medicine, Experimental | DNA repair | Sugars | Cancer | Monosaccharides | Drugs | Genetic variability | DNA damage | Homologous recombination | Clinical trials | Cytotoxicity | Homology | Radioresistance | Proteins | Rad51 protein | Ribose | Damage | Repair | Deoxyribonucleic acid--DNA | Adenosine diphosphate | Poly(ADP-ribose) polymerase | Radiation therapy | Gene expression | Biomarkers | Protein expression | Immunoreactivity | Solid tumors | Tumors | Index Medicus
Journal Article